Implements oral fluid tests which tests a person's saliva for the presence of cannabis.
Summary
Bill A05271 amends the vehicle and traffic law and the navigation law to implement oral fluid tests for detecting cannabis in saliva. The bill defines an 'oral fluid test' as a standardized preliminary saliva analysis test validated by the National Highway Traffic Safety Administration. It mandates that individuals operating a motor vehicle or vessel involved in an accident or violating traffic laws must submit to an oral fluid test at the request of a police officer. If the test indicates the presence of cannabis, further chemical testing may be requested.
Impact
The bill's implementation will alter existing protocols for testing drivers and vessel operators suspected of being under the influence of cannabis. It introduces oral fluid tests as a new method for law enforcement to assess impairment, thereby affecting how sobriety checks are conducted and potentially leading to changes in legal proceedings related to driving under the influence of drugs. This could also influence the admissibility of test results in court, as the bill specifies how such evidence should be treated.
Sentiment
The general sentiment around Bill A05271 appears to be mixed. While there is support for enhancing road safety and addressing cannabis use among drivers, concerns have been raised regarding the reliability and accuracy of oral fluid tests compared to traditional methods. The bill was held for consideration by the Assembly Transportation Committee, indicating ongoing discussions and potential amendments before further action.
Contention
Notable points of contention include the reliability of oral fluid tests and their potential impact on civil liberties. Some legislators express concerns about the accuracy of saliva tests in determining impairment, while others argue that the bill is necessary for public safety. There is also debate over the implications for individuals who may test positive for cannabis without being impaired, particularly in light of varying cannabis consumption laws.
Establishes an oral fluid task force to study and make recommendations on best practices for the testing of oral fluids to determine impairment due to drug intoxication while operating a motor vehicle in the state; replaces the word "saliva" with the term "oral fluid" and relates to the testing of oral fluids.
Payment rates established for certain substance use disorder treatment services, and vendor eligibility recodified for payments from the behavioral health fund.
Cover Outstanding Vulnerable Expansion-eligible Residents Now Act or the COVER Now Act This bill establishes a demonstration program to allow local governments to provide health benefits to the Medicaid expansion population in states that have not expanded Medicaid. Under the program, local governments may provide coverage for individuals who are newly eligible for Medicaid under the Patient Protection and Affordable Care Act (i.e., the Medicaid expansion population) for a maximum of 10 years, or until their respective states expand Medicaid. The bill provides a 100% federal matching rate for the first three years of program participation. The bill prohibits states from taking certain actions against participating localities, such as withholding funding, increasing taxes, or restricting provider participation. States that violate these requirements are subject to certain funding penalties.